FindTrial
Sign In

Case Report: Complete Remission of Parotid Lymphoepithelial Carcinoma Following Immunochemotherapy

Case Report: Complete Remission of Parotid Lymphoepithelial Carcinoma Following Immunochemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093313
Enrollment
Unknown
Registered
2024-12-02
Start date
2024-12-02
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parotid Lymphoepithelial Carcinoma

Interventions

Observation group:None

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients newly diagnosed and treated for parotid lymphoepithelial carcinoma with complete medical and examination records; all patients were pathologically confirmed to have parotid lymphoepithelial carcinoma; all patients underwent immunotherapy-based comprehensive treatment; and complete follow-up data were available.

Exclusion criteria

Exclusion criteria: Patients who did not complete immunotherapy after surgery; those who had undergone chemotherapy, radiotherapy, or other anti-tumor treatments before surgery; those with other malignant tumors; and those with incomplete follow-up data.

Design outcomes

Primary

MeasureTime frame
OS;—

Countries

China

Contacts

Public Contactshule xie

Sun Yat-sen Memorial Hospital, Sun Yat-sen University.

xieshuleah@163.com+86 156 9243 4749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026